Allogeneic T cells cause acute renal injury after hematopoietic cell transplantation.


Journal

Blood advances
ISSN: 2473-9537
Titre abrégé: Blood Adv
Pays: United States
ID NLM: 101698425

Informations de publication

Date de publication:
28 Nov 2023
Historique:
accepted: 21 08 2023
received: 09 01 2023
medline: 27 11 2023
pubmed: 25 9 2023
entrez: 25 9 2023
Statut: ppublish

Résumé

Acute kidney injury (AKI) is a frequent complication of allogeneic hematopoietic cell transplantation (allo-HCT). There are many causes of AKI after allo-HCT, but it is unknown whether renal acute graft-versus-host disease (aGVHD) caused by direct allogeneic donor T-cell-mediated renal damage contributes. Here, we tested whether allogeneic donor T cells attack kidneys in murine models of aGVHD. To avoid confounding effects of nephrotoxic agents, we did not administer immunosuppressants for GVHD prophylaxis. We found that urinary N-acetyl-β-D-glucosaminidase, a marker of tubular injury, was elevated in allogeneic recipients on day 14 after allogeneic bone marrow transplantation. Donor major histocompatibility complex-positive cells were present and CD3+ T cells were increased in the glomerulus, peritubular capillaries, interstitium, and perivascular areas in the kidneys of allo-HCT recipient mice. These T cells included both CD4+ and CD8+ cells with elevated activation markers, increased exhaustion markers, and greater secretion of proinflammatory cytokines and cytotoxic proteins. Consistent with allo-T-cell-mediated renal damage, expression of neutrophil gelatinase-binding lipocalin, a marker of AKI, and elafin, a marker of aGVHD, were increased in renal tissue of allogeneic recipients. Because apoptosis of target cells is observed on histopathology of aGVHD target tissues, we confirmed that alloreactive T cells increased apoptosis of renal endothelial and tubular epithelial cells in cytotoxic T-lymphocyte assays. These data suggest that immune responses induced by donor T cells contribute to renal endothelial and tubular epithelial cell injury in allo-HCT recipients and that aGVHD may contribute to AKI after allo-HCT.

Identifiants

pubmed: 37748044
pii: 498046
doi: 10.1182/bloodadvances.2023009721
pmc: PMC10690563
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6936-6948

Subventions

Organisme : NHLBI NIH HHS
ID : K08 HL157619
Pays : United States

Informations de copyright

© 2023 by The American Society of Hematology. Licensed under Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0), permitting only noncommercial, nonderivative use with attribution. All other rights reserved.

Références

Lancet. 2009 May 2;373(9674):1550-61
pubmed: 19282026
QJM. 2020 Sep 1;113(9):621-632
pubmed: 32101318
Nat Microbiol. 2019 May;4(5):800-812
pubmed: 30858572
Blood. 2011 Jul 7;118(1):192-204
pubmed: 21471527
Biol Blood Marrow Transplant. 2012 Aug;18(8):1150-63
pubmed: 22510384
Sci Transl Med. 2010 Jan 6;2(13):13ra2
pubmed: 20371463
Biol Blood Marrow Transplant. 2015 Apr;21(4):589-603
pubmed: 25639770
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Nat Rev Nephrol. 2019 Apr;15(4):220-239
pubmed: 30651611
N Engl J Med. 2016 Jun 9;374(23):2256-67
pubmed: 27276563
Am J Transplant. 2020 Sep;20(9):2318-2331
pubmed: 32463180
Clin Exp Immunol. 2018 May;192(2):142-150
pubmed: 29453850
J Nippon Med Sch. 2020 Mar 11;87(1):7-12
pubmed: 31776318
Hypertension. 2020 Dec;76(6):1868-1878
pubmed: 33131309
Biol Blood Marrow Transplant. 2008 Jan;14(1):125-31
pubmed: 18158969
Am J Clin Pathol. 2016 May;145(5):591-603
pubmed: 27247365
Bone Marrow Transplant. 2016 Jun;51(6):755-62
pubmed: 26855155
N Engl J Med. 2017 Nov 30;377(22):2167-2179
pubmed: 29171820
Front Immunol. 2022 Jan 04;12:779881
pubmed: 35058924
Clin J Am Soc Nephrol. 2015 Jan 7;10(1):12-20
pubmed: 25388519
Cell Transplant. 2017 Aug;26(8):1428-1440
pubmed: 28901194
Best Pract Res Clin Haematol. 2008 Jun;21(2):139-48
pubmed: 18503982
Bone Marrow Transplant. 2010 Jan;45(1):153-8
pubmed: 19430501
PLoS One. 2014 Dec 26;9(12):e115399
pubmed: 25541735
Biol Blood Marrow Transplant. 2009 Jan;15(1):21-9
pubmed: 19135939
Bone Marrow Transplant. 2006 Sep;38(5):351-7
pubmed: 16862167
Blood. 2017 Mar 30;129(13):1747-1752
pubmed: 28153825
Transplant Cell Ther. 2021 Feb;27(2):115-124
pubmed: 33017661
Biol Blood Marrow Transplant. 2019 Oct;25(10):1920-1924
pubmed: 31271886
Blood. 2012 Apr 19;119(16):3844-53
pubmed: 22101894
Clin J Am Soc Nephrol. 2020 Feb 7;15(2):289-297
pubmed: 31836598
Am J Transplant. 2014 Feb;14(2):255-71
pubmed: 24401076
Biochem Soc Trans. 2011 Oct;39(5):1450-4
pubmed: 21936832
Blood. 1996 Oct 15;88(8):3230-9
pubmed: 8963063
Clin J Am Soc Nephrol. 2009 Feb;4(2):481-508
pubmed: 19218475
Intern Med. 2012;51(16):2105-10
pubmed: 22892486
Lancet Haematol. 2020 Feb;7(2):e157-e167
pubmed: 32004485
Biol Blood Marrow Transplant. 2015 Mar;21(3):389-401.e1
pubmed: 25529383
Biol Blood Marrow Transplant. 2018 Mar;24(3):571-580
pubmed: 29155318
Blood. 2021 Dec 2;138(22):2165-2172
pubmed: 34482399
Nat Med. 2005 Nov;11(11):1244-9
pubmed: 16227991
Blood. 2013 May 16;121(20):4231-41
pubmed: 23520337

Auteurs

Masahiro Miyata (M)

Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.

Eri Matsuki (E)

Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.

Kazunobu Ichikawa (K)

Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.

Tomohiro Takehara (T)

Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.

Yuka Hosokawa (Y)

Division of Hematology and Cell Therapy, Department of Internal Medicine III, Yamagata University School of Medicine, Yamagata, Japan.

Erika Sekiguchi (E)

Keio University Hospital, Tokyo, Japan.

Daniel Peltier (D)

Division of Pediatric Hematology and Oncology, Department of Pediatrics, Herman B. Wells Center for Pediatric Research, Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN.

Pavan Reddy (P)

Dan L. Duncan Comprehensive Cancer Center, Baylor College of Medicine, Houston, TX.

Kenichi Ishizawa (K)

Division of Hematology and Cell Therapy, Department of Internal Medicine III, Yamagata University School of Medicine, Yamagata, Japan.

Masafumi Watanabe (M)

Department of Cardiology, Pulmonology, and Nephrology, Yamagata University School of Medicine, Yamagata, Japan.

Tomomi Toubai (T)

Division of Hematology and Cell Therapy, Department of Internal Medicine III, Yamagata University School of Medicine, Yamagata, Japan.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH